0001250853-17-000065.txt : 20170720 0001250853-17-000065.hdr.sgml : 20170720 20170720161738 ACCESSION NUMBER: 0001250853-17-000065 CONFORMED SUBMISSION TYPE: D/A PUBLIC DOCUMENT COUNT: 1 ITEM INFORMATION: 06b FILED AS OF DATE: 20170720 DATE AS OF CHANGE: 20170720 EFFECTIVENESS DATE: 20170720 FILER: COMPANY DATA: COMPANY CONFORMED NAME: Nacuity Pharmaceuticals, Inc. CENTRAL INDEX KEY: 0001690279 IRS NUMBER: 813011847 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: D/A SEC ACT: 1933 Act SEC FILE NUMBER: 021-289536 FILM NUMBER: 17974559 BUSINESS ADDRESS: STREET 1: FORT WORTH CLUB BLDG. STREET 2: 306 W. 7TH STREET, SUITE 310 CITY: FORT WORTH STATE: TX ZIP: 76102 BUSINESS PHONE: 817-336-3000 MAIL ADDRESS: STREET 1: FORT WORTH CLUB BLDG. STREET 2: 306 W. 7TH STREET, SUITE 310 CITY: FORT WORTH STATE: TX ZIP: 76102 D/A 1 primary_doc.xml X0708 D/A LIVE 0001690279 Nacuity Pharmaceuticals, Inc. FORT WORTH CLUB BLDG. 306 W. 7TH STREET, SUITE 310 FORT WORTH TX TEXAS 76102 817-336-3000 DELAWARE None None Corporation true 2016 William Halden Conner Fort Worth Club Bldg. 306 W. 7th Street, Suite 310 Fort Worth TX TEXAS 76102 Executive Officer Director President and Chief Executive Officer David J. Wohlberg 1801 Century Park East Suite 1600 Los Angeles CA CALIFORNIA 90067 Director Sanford J. Hillsberg 1801 Century Park East Suite 1600 Los Angeles CA CALIFORNIA 90067 Director G. Michael Wall, Ph.D. Fort Worth Club Bldg. 306 W. 7th Street, Suite 310 Fort Worth TX TEXAS 76102 Executive Officer Vice President of Research and Development Charles Lieser Fort Worth Club Bldg. 306 W. 7th Street, Suite 310 Fort Worth TX TEXAS 76102 Executive Officer Chief Financial Officer Isaac Blech 21st Century Investors Group 75 Rockefeller Plaza, 29th Floor New York NY NEW YORK 10019 Director Richard Chin, M.D. Kindred Biosciences, Inc. 58 West Portal Avenue, #105 San Francisco CA CALIFORNIA 94127 Director Dr. Gerald D. Cagle 6309 Greenway Road Fort Worth TX TEXAS 76116 Director Biotechnology Decline to Disclose 06b true 0001250853-17-000059 2017-06-15 false true true true Units comprised of Convertible Preferred Shares plus Common Stock Purchase Warrants false 25000 Maxim Group LLC 120708 Clifford Adam Teller 4631188 405 Lexington Avenue New York NY NEW YORK 10174 All States true 10000000 9227000 773000 false 125 922700 0 Commissions include a Unit Purchase Option to acquire 922,700 Units at an exercise price of $2 per Unit 0 false Nacuity Pharmaceuticals, Inc. /s/ Halden Conner Halden Conner President and Chief Executive Officer 2017-07-20